Previous work has shown that the Pseudomonas-derived protease, pseudomonas elastase (PAE), can modify transferrin to form iron complexes capable of catalyzing the formation of hydroxyl radical (-OH) from neutrophil (PMN)-derived superoxide (02-) and hydrogen peroxide (H202).
Introduction
Sites of Pseudomonas aeruginosa infection are notable for an intense infiltration of neutrophils (PMNs) and can exhibit marked tissue damage. A variety of PMN-and bacteria-derived secretory products, particularly proteases, have been suggested to play a role in tissue injury ( [1] [2] [3] [4] [5] [6] [7] [8] ). Neutrophil oxidant formation has also been implicated as an important contributor to tissue injury at sites of inflammation under a variety of conditions (9) (10) (11) (12) . However, the role of these PMN-derived products in P. aeruginosa-mediated tissue injury has not been as extensively investigated.
Neutrophil-derived superoxide (-°0) and hydrogen peroxide (H202) are only moderately reactive oxidants. In the presence of an exogenous iron catalyst, *°2-and H202 can react to form the highly cytotoxic -OH via the Haber-Weiss reaction (13) . A number of in vitro and in vivo studies have suggested that -OH may be one of the reactive oxygen species involved in tissue injury at sites of inflammation (14) . Because PMNs do not possess an endogenous catalytic iron source for -OH generation, in order for this species to be produced in vivo, an exogenous catalytic iron complex must be present (3, 15) . In vivo, almost all extracellular iron is tightly bound to host ironbinding proteins (16) (17) (18) .
Transferrin, a 76,000-80,000-D protein, is the principal iron-binding protein in serum and is present in lower concentrations at mucosal surfaces (18) . The iron-binding protein, lactoferrin, provides the majority of the iron-chelating capacity at mucosal surfaces although transferrin is also present (18) . When bound to either of these proteins, iron cannot act as a -OH catalyst (19) (20) (21) (22) . This property may allow transferrin and lactoferrin to function as inhibitors of oxidant-mediated tissue injury (23, 24) .
A number of PMN-and bacteria-derived proteases cleave transferrin and/or lactoferrin into smaller protein fragments (25) (26) (27) (28) (29) (30) . We (31) . Fe-transferrin cleaved with human neutrophil elastase (HNE), trypsin, and pseudomonas alkaline protease did not catalyze detectable amounts of -OH formation (3 1). Attesting to the potential clinical relevance of these findings, we consistently detected transferrin cleavage products in bronchoalveolar lavage (BAL) specimens from P. aeruginosa-infected cystic fibrosis patients but not in normal individuals (32) .
Microv'ascular endothelial cells are among the cells which appear to be injured at sites of P. aeruginosa infection such as the lung (33) (34) (35) (36) . These cells are also well recognized for their susceptibility to oxidant-mediated injury (37) . Therefore, we examined the possibility that protease-cleaved Fe-transferrin could augment oxidant-mediated pulmonary artery endothelial cell injury via -OH formation. Here we report the results of these studies and discuss them as a potential mechanism of inflammatory tissue injury.
Methods
Reagents. PAE (64.7 U/mg protein) was obtained from Nagase Biochemicals (Tokyo, Japan). Porcine pancreatic elastase (PPE) (70 U/ mg solid, 120 U/mg protein), trypsin (12,600 U/mg solid, 13,000 U/ mg protein), apo-transferrin, Fe-transferrin, catalase, CuZn-superoxide dismutase (SOD), a-phenyl-n-terbutyl-nitrone (PBN), 4 Cell culture. Pulmonary artery endothelial cells were obtained from porcine pulmonary artery using techniques described by Shasby et al. (39) . For 51Cr release experiments (see below), endothelial cell monolayers from passes 5-9 were plated at a concentration of 3.75 X 104 cells per well in 48-well tissue culture plates (Costar Corp., Cambridge, MA) in 0.5 ml medium 199 (University of Iowa Cancer Facility) with 10% serum, basal medium amino acids, basal minimal essential vitamins, 2 mM 1-glutamine, and 10 U/ml penicillin/streptomycin (Gibco Laboratories, Grand Island, NY). The plates were then incubated at 37°C, 5% CO2 for 4-5 d. For spin trapping experiments, confluent monolayers of porcine pulmonary artery endothelial cells were generated on microcarrier beads (Cytodex 3; Pharmacia LKB Biotechnology, Piscataway, NJ) using previously described methods (39, 40) . Multiple cell lines (passages 5-9) were used for these studies and were cultured for 2-3 d after confluence. Before use, cell coated beads were washed free of culture media with HBSS three times and resuspended in HBSS at 25% (vol/vol) microcarrier beads (0.5-1.0 X I07 cells/ml). For all methods involving endothelial cells, each experiment was performed with the transferrin cleavage products and the appropriate paired controls to account for the variability in injury susceptibility of each cell line due to the length of time it was in passage.
Human PMN isolation. PMNs were separated from whole blood as previously described (41) . Briefly, whole blood was Dextran sedimented, and the leukocyte-rich layer was centrifuged through FicollHypaque. Erythrocyte contamination of the PMN-containing fractions was removed by hypotonic lysis. Final PMN suspensions (> 95% purity) were maintained at 4°C in HBSS and used within 2 h.
5'Chromium release assay. This assay was performed as described previously with slight modification (11) . For experiments in which protease cleaved Fe(apo)-transferrin (4 mg/ml) was used, endothelial cells were allowed to preincubate for 30 min in the presence of these compounds or controls (media alone) before the addition of oxidant agents (H202, xanthine/xanthine oxidase, or PMA-stimulated PMNs). Antioxidant compounds and *OH scavengers (500 U/ml catalase, 50 AM DMTU, 300 U/ml SOD, 140 mM DMSO, 10 mM PBN, 10 mM 4-POBN) were added before the 30-min preincubation in selected experiments. The concentration of oxidant used was titrated to produce no more than 15% of maximum 5 Formation of TBA-reactive 2-deoxyribose oxidation products. The assay was performed using previously described methods (31, 42, 43) .
Briefly, 1-ml reaction mixtures were prepared using hypoxanthine (2 mM) and 2-deoxyribose (5 mM), with or without iron chelates such that the final iron concentration was 25 MlM. Xanthine oxidase (15 mU/ml) was added, and the mixture was incubated at 37TC (rotating incubator) for 15 min. The mixture was then added to 0.5 ml of 1% TBA and 1.0 ml of 6% tricheoroacetic acid (TCA) and heated to 100°C for 10 min. The protein was pelleted (1,000 g, 5 min), and the absorbance at 532 nm of the supernatant was determined spectrophotometrically (model DW-2000; SLM-AMINCO, Urbana, IL).
Spin trapping. Spin trapping was performed using the previously described methods ( 11 incubated with uncleaved Fe-transferrin or PAE alone followed by H202 addition yielded 51Cr release which was not statistically different from H202 alone ( Fig. 1 A) . Using xanthine/xanthine oxidase as the oxidant source, results were similar to those seen with H202 ( Fig. 1 B) . 51Cr release was 15.8% of maximum with PAE-cleaved Fe-transferrin as compared with 2.3% with xanthine/xanthine oxidase alone (n = 6, P < 0.01). Once again, control Fe-transferrin and PAE alone did not augment xanthine/xanthine oxidase-associated cell injury ( Fig. 1 B) . Experiments performed with increasing concentrations of PAE-cleaved Fe-transferrin and Fe-transferrin and PAE controls in the presence of 10 tM H202 revealed a dose-dependent increase in 5"Cr release with the Fe-transferrin cleavage products with minimal increases in Fe-transferrin and PAE controls (Fig.  2) . Although the higher concentration of the Fe-transferrin cleavage products yielded the most 5"Cr release, the variability between the triplicate samples also increased. In addition, this Fe-transferrin concentration is in excess of that expected under most in vivo conditions, as serum concentrations of Fe-transferrin range from 2 to 4 mg/ml (44) . Therefore, the concentrations of Fe-transferrin and PAE present in all subsequent endothelial cell injury assays were 4 mg/ml and 3 ,pg/ml, respectively.
As PMNs are present in high concentrations at sites of P. aeruginosa infection and other forms of inflammation, PMNs would likely serve as the source of H202 and *°2-in vivo. Thus, experiments were repeated using PMA-stimulated PMNs as the oxidant source in place of H202 and xanthine/xanthine oxidase in the endothelial cell injury assay. The results were similar in that 51Cr release increased from 2.4 to 17% of maximum in the presence of PAE-cleaved Fe-transferrin (n = 12, P < 0.001) but not PAE alone (Fig. 3) . Non-protease-treated Fe-transferrin also caused a statistically significant increase in injury above PMNs alone. However, the magnitude of the increase was still significantly less than PAE-cleaved Fe-transferrin (Fig. 3) .
To further assess the mechanism whereby PAE-cleaved Fe cant increase in endothelial cell injury regardless of the oxidant used (Fig. 4) , establishing the role of iron in mediating injury. The iron responsible for injury appears to be that associated with the cleaved Fe-transferrin and not simply iron released from the protein during cleavage, as the addition of free iron in the form of FeCl3 (100 ILM) did not result in a significant increase in injury when added to each oxidant system (Fig. 4) . Fe-transferrin treated with heat-inactivated PAE (100°C for 10 min) also failed to augment oxidant-mediated endothelial cell injury (Fig. 4) (31 ) . Postulating that the iron-dependent augmentation in endothelial cell injury results from -OH formation, studies assessing the role of -OH scavengers and other antioxidant compounds in inhibiting cell injury were performed. Regardless of whether H202 or PMA-stimulated PMNs were used as the oxidant source, the addition of catalase and DMTU to test wells containing PAE-cleaved Fe-transferrin resulted in a statistically significant decrease in 51Cr release (Table I ). The addition of SOD and DMSO had no significant protective effects (Table I ). The site of *OH formation is a critical element in determining the magnitude of resulting cell injury. To further explore the location of the iron-dependent oxidant leading to cytotoxicity, the capacity of two additional -OH scavengers with differing hydrophobicity to inhibit cell injury was measured. Spin traps are nitrones (or nitroso compounds) which readily react with oxidant species (45) . The hydrophobic spin trap, PBN, demonstrated the most protection (58.2%) of all the inhibitors studied, whereas the hydrophilic spin trap, 4-POBN, showed no significant effect (Table I) . These results are consistent with the possibility that formation of reactive oxygen intermediates, such as *OH at hydrophobic sites, contributes to endothelial cell injury resulting from the presence of PAE-cleaved Fe-transferrin.
Given the above data, spin trapping studies were performed to provide additional evidence supporting the role of -OH in mediating endothelial cell injury. The the presence of noncleaved Fe-transferrin (Fig. 5) . The substitution of PAE-cleaved apotransferrin for cleaved Fe-transferrin in the endothelial cell and PMA-stimulated PMN system eliminated spin adduct generation, demonstrating the necessity for iron in the system and providing further evidence for involvement of the Haber-Weiss reaction. When H202 was used in place of PMA-stimulated PMNs, the results were similar (data not shown).
The presence of *02-generated by the xanthine/xanthine oxidase reaction or by PMA-stimulated PMNs systems provides a means of reducing the Fe"3 bound to transferrin to Fe+2 which would be required for the formation of -OH via the HaberWeiss reaction in our cell injury and spin trapping systems. In contrast, with the use of H202 as an oxidant source, there is no source of '02 to reduce the Fe"3 used with transferrin to form *OH in the classic Haber-Weiss reaction. Nevertheless, as discussed above, cleaved Fe-transferrin augmented H202-mediated endothelial cell injury and yielded spin trap detectable -OH. One possible explanation for these observations was that the endothelial cell was providing the reducing equivalents required for the formation of Fe+2 which then interacted with H202 to generate 'OH. However, spin trapping studies in which H202 was mixed with PAE-cleaved transferrin also in the absence of endothelial cells also demonstrated significant -OH formation. This was not observed with noncleaved Fe-transferrin or H202 alone (Fig. 6 ). This suggests that the endothelial cell itself does not need to serve as a reducing source in order for 'OH or an oxidant with properties analogous to -OH to be generated during the reaction of H202 and PAE-cleaved Fe-transferrin.
The ability of Fe-transferrin cleaved with other proteases to augment oxidant-mediated endothelial cell injury. Sites of P. aeruginosa infection and other types of inflammation are characterized by increased proteolytic activity mediated by proteases other than PAE. These proteases are also known to cleave Fe-transferrin (3, (46) (47) (48) (49) (50) . In an earlier study, we found that although trypsin and human PMN elastase cleave Fe-transferrin, these cleavage products lacked the ability to catalyze -OH generation as assessed using the formation of TBA-reactive 2-deoxyribose oxidation products as the -OH detection system (31 (Fig. 8) . consistent with the above spin trapping studies, -OH was detected regardless of the presence or absence of endothelial cells (data not shown). The quantity of -OH generated, however, was less than that seen with PAEcleaved Fe-transferrin (Fig. 8) generating more replicates than performed in the earlier study (31), we were able to show a small but statistically significant increase in detectable -OH formation with trypsin-cleaved Fetransferrin relative to the Fe-transferrin control (Table II) . PPE- cleaved Fe-transferrin also demonstrated a significant increase in *OH formation compared with the Fe-transferrin control (Table II). with the amount of cell injury observed for all three protease cleavage products in the 5"Cr release assay (Fig. 7) .
Using a method for detecting the formation of TBA-reactive 2-deoxyribose oxidation products, we reported previously that *OH formation could be catalyzed by PAE-cleaved Fe-transferrin, but not with Fe-transferrin cleaved with trypsin and human PMN elastase (31 ) . This assay, however, is somewhat less sensitive and specific than spin trapping for detecting *OH. As the above cell injury and spin trapping studies appeared to demonstrate a discrepancy with our previous results, *OH formation was again assessed using the deoxyribose assay. By P. aeruginosa infections are characterized by marked inflammation and subsequent tissue injury which is thought to contribute to the high morbidity and mortality seen in patients with pneumonia and cystic fibrosis (1, 34, 52, 53) . Bacteria-and PMN-derived proteases and to a lesser extent PMN oxidant formation have both been implicated in mediating this tissue injury (1) (2) (3) (4) (5) (6) (7) 54) , but the primary mechanism is largely unknown. Previous data from our laboratory have suggested that *OH formation may be involved in protease-mediated injury as PAE, a P. aeruginosa-derived protease, can cleave Fe-transferrin into smaller iron chelates which in the presence of an oxidant source are able to catalyze *OH formation (31) . Based on these findings and that acute, and to a lesser extent chronic, forms of P. aeruginosa infection of the lung have been shown to result in pulmonary microvasculature damage (33) (34) (35) (36) , the ability of the PAE and other protease-cleaved Fe-transferrin to augment oxidant-mediated endothelial cell injury via -OH formation was examined.
Using a 5"Cr release assay, we demonstrated a significant augmentation in oxidant-mediated porcine pulmonary artery endothelial cell injury with PAE-, trypsin-, and PPE-cleaved Fetransferrin, regardless of the oxidant source employed, including PMA-stimulated PMNs. Fe-transferrin alone, the proteases alone, and Fe-transferrin treated with heat-inactivated protease all failed to demonstrate any augmentation in cell injury, establishing the need for an active protease in combination with Fetransferrin in mediating injury. This process also appears to be dependent on iron associated with Fe-transferrin, as no augmentation in cell injury was seen with protease-cleaved apotransferrin or FeCl3. Control studies performed with the iron chelates in the absence of an oxidant source failed to induce cell injury. This is consistent with the hypothesis that the iron is acting as a catalyst for the Haber-Weiss reaction rather than through the direct induction of membrane peroxidation. (56) , as spin trapping studies performed in which H202 and proteasecleaved Fe-transferrin were mixed in the absence of endothelial cells yielded comparable quantities of -OH. In these H202 studies, the species generated is either 'OH or a 'OH-like compound which results from the interaction of H202 and Fe"3 and which is able to cause cell injury in a fashion analogous to 'OH. Ferryl species exhibit many of the properties of -OH and could possibly be generated under such conditions.
The results of our studies are consistent with the hypothesis that protease-cleaved Fe-transferrin enhances oxidant-mediated pulmonary artery endothelial cell injury through the generation of new iron chelates capable of acting as -OH catalysts. A crucial issue in in vitro studies such as the one reported here is the applicability of these findings to in vivo conditions. Due to obvious technical limitations, no data exist as to the concentration of proteases, transferrin, and transferrin cleavage products present at or near the pulmonary microvascular surface during either acute or chronic forms of P. aeruginosa lung infection. However, the concentrations of proteases and Fe-transferrin used in this study approximated those reported to be found in vivo at other nearby sites. In the case of transferrin this includes serum (44) and BAL fluid (57) . It should be recognized though that wide variations have been reported in the concentration of enzymatically active PAE present at sites of infection with this organism (3, 46, (57) (58) (59) (60) . Reports of PAE activity in airway fluids from P. aeruginosa-infected cystic fibrosis patients have varied from nearly 200 pg/ml to none. Unfortunately, none of these studies address the PAE concentrations present near cell surfaces to which P. aeruginosa are attached, where levels of the enzyme could be very high. There are no solid data on levels of PAE present at sites of human P. aeruginosa infection in conditions other than cystic fibrosis. PPE was used as a HNE analogue in the present study as it has been shown to have similar enzymatic properties and is more economical (51) . Limited data are available measuring in vivo concentrations of HNE (46, 47, 61) . One study found the HNE concentrations in sputum from cystic fibrosis patients to be a mean of 55 ag/ml (range 16-87 pg/ml) (46) with other reports finding higher levels (61) . Of note, sputum from patients with more advanced disease exhibited increased elastolytic activity (46) . Given the approximate 100-fold dilution BAL specimens are felt to represent (62) , HNE concentrations found in vivo are in the range of PPE concentrations used in this study. It is known that trypsin is released from damaged cells (63, 64) , but no data are available regarding in vivo trypsin concentrations at sites of pulmonary inflammation and injury, thus we can only speculate that the concentration used in this study is of physiologic importance.
The goal of this study was to assess the effects of the protease-cleaved Fe-transferrin on oxidant-mediated injury of the pulmonary microvasculature. Thus, these findings cannot be extrapolated to events occurring at the respiratory epithelium, which is the subject of future investigations. The in vitro experimental model used for these studies also has limitations when interpreting these results in the context of the in vivo microvasculature. Our system contained none of the protease inhibitors, antioxidants, or iron-binding proteins that could be expected to be found in vivo. Proteases, in addition to those tested, could also be expected to be found at inflammatory sites and may have similar effects. However, recent studies from our own laboratory have provided additional evidence supporting the biologic relevance of the in vitro observations reported in this communication (32) . Using a sensitive immunoblot system, transferrin cleavage products were detected in 21 out of 22 bronchoalveolar lavage samples from P. aeruginosa-infected cystic fibrosis patients and 5 out of 13 BAL samples from non-cystic fibrosis individuals with P. aeruginosa pulmonary infections. The presence of transferrin degradation products in airways does not appear to reflect a normal physiologic process as no such products were detected in healthy controls (n = 8). The ability of these transferrin cleavage products to catalyze *OH formation and cause tissue injury was not assessed in this study, but based on the present in vitro studies it is likely that these chelates are able to act as *OH catalysts and could potentially contribute to P. aeruginosa-associated tissue injury.
In summary, we have obtained in vitro evidence that protease-cleaved Fe-transferrin augments oxidant-mediated endothelial cell injury via formation of the *OH or another iron-dependent oxidant. This process may contribute to P. aeruginosaassociated microvascular lung injury. Furthermore, the findings with PPE-cleaved Fe-transferrin in particular suggest that any condition which leads to an increase in PMN elastase also has the capacity to generate these catalytic Fe-transferrin products. Thus, it seems that *OH generation resulting from the cleavage of Fe-transferrin may contribute to other types of inflammatory microvascular injury characterized by increased proteolytic activity. Further investigations into the role of transferrin cleavage as a contribution to inflammatory tissue injury in vivo are indicated.
